In trading on Wednesday, shares of Diebold, Inc. ( DBD) touched a new 52-week high of $35.96/share. That's a 30.34% rise, or $8.37 per share from the 52-week low of $27.59 set back on 03/06/2013. That means at today's intraday high, any investor who purchased DBD stock any time over the past 52 weeks has an unrealized gain, including company insiders.Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, DBD has seen 4 different instances of insiders buying over the trailing six month period.
|08/30/2013||Andreas W. Mattes||President and CEO||1,000||$28.50||$28,500.00|
|09/09/2013||John D. Kristoff||VP, Chief Communications Ofcr.||200||$29.16||$5,831.98|
|12/06/2013||Andreas W. Mattes||President and CEO||500||$32.88||$16,438.10|
|12/11/2013||Sheila M. Rutt||VP, Chief HR Officer||150||$31.85||$4,776.90|
|12/11/2013||Stefan Merz||Sr. VP, Strategic Projects||300||$32.07||$9,622.26|
|12/11/2013||John D. Kristoff||VP, Chief Communications Ofcr.||100||$31.67||$3,167.00|
In afternoon trading on Wednesday, DBD shares are changing hands at $35.75/share, slightly below the new 52-week high.